Phase 3 Readout~month

Phase 3 Topline: A Phase 2/3 Randomized, Controlled Study of CTX-009 in Combination With Paclitaxel Versus Paclitaxel

Indication
Biliary Tract Cancer; Cholangiocarcinoma; Gall Bladder Cancer

Other upcoming events for CMPX

Phase 3 ReadoutPhase 3 Topline: A Phase 2/3 Randomized, Controlled Study of CTX-009 in Combination With Paclitaxel Versus Paclitaxel

Track this catalyst and more

Get real-time alerts, AI-powered analysis, and full catalyst coverage.

Start FreeFull Calendar
    Phase 3 Topline: A Phase 2/3 Randomized, Controlled Study of CTX-009 in Combination With Paclitaxel Versus Paclitaxel — CMPX Phase 3 Readout | BioSniper